GlassScriptPhysician profile
Heather M Mulherin
NPI 1508041732
$1,137.32
in general payments reported to CMS, 2019-2025
20 companies · $394 in 2025
The $394 reported for 2025 was more than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $187 · 2022: $116 · 2023: $251 · 2024: $190 · 2025: $394.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $835.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $834.84 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Neurelis, INC. | $219.54 | 2021-2025 | Valtoco |
| Ironshore Pharmaceuticals INC. | $187.56 | 2022-2024 | Jornay Pm |
| Supernus Pharmaceuticals, INC. | $156.80 | 2021-2025 | Qelbree |
| Tris Pharma INC | $120.59 | 2021-2024 | Dyanavel Xr |
| Collegium Pharmaceutical, INC. | $87.34 | 2025 | Jornay Pm |
| Alk-Abello, INC | $52.45 | 2025 | Neffy |
| Otter Pharmaceuticals, LLC | $33.80 | 2025 | Sympazan |
| Corium, LLC | $32.09 | 2022-2025 | Azstarys |
| Pfizer INC. | $29.75 | 2021-2023 | |
| Sanofi Pasteur INC. | $29.26 | 2021-2022 | |
| Takeda Pharmaceuticals U.S.A., INC. | $27.02 | 2021 | |
| Adlon Therapeutics L.P. | $26.87 | 2021 | |
| Soleno Therapeutics, INC. | $23.75 | 2025 | Vykat Xr |
| Sanofi-Aventis U.S. LLC | $23.13 | 2025 | |
| Alexion Pharmaceuticals, INC. | $15.48 | 2023 | Strensiq |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Travere Therapeutics, INC. | $15.38 | 2023 | Cholbam |
| Cranial Technologies, INC | $15.10 | 2022 | |
| Astrazeneca Pharmaceuticals LP | $14.58 | 2023 | Flumist Quadrivalent |
| Vertical Pharmaceuticals, LLC | $14.13 | 2025 | Relexxii |
| Neos Therapeutics, LP | $12.70 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Heather Mulherin listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.